CTNM insider buying & filings

CTNMContineum Therapeutics, Inc.

NasdaqGS · Healthcare · $637.68M

$17.24

+4.17% · Sep 2

42 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Aug 3 · scanned 5m ago

Price · 1Y · daily● 25 sells

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$637.68M

Float

27.8M

84% public

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Aug 3SELLStengone Carmine N.10b5-1CEO and Presidentdirect2,500 @ $16.01$40.0K

Aug 3EXERCISEStengone Carmine N.10b5-1CEO and Presidentdirect2,500 @ $1.01$2.5K

Jul 8SELLStengone Carmine N.10b5-1CEO and Presidentdirect2,500 @ $16.00$40.0K

Jul 8EXERCISEStengone Carmine N.10b5-1CEO and Presidentdirect2,500 @ $1.01$2.5K

Jul 2SELLLorrain Daniel S.Chief Scientific Officerdirect2,501 @ $16.24$40.6K

Context

Wall St

$22.86 avg target

+32.6% vs today · 7 analysts · consensus Strong Buy

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Earnings · EPS vs forecast

3 of 4 quarters beat

Q2 '26−$0.40 act+$0.05

Q1 '26−$0.39 act+$0.14

Q4 '25−$0.49 act−$0.10

Q3 '25−$0.45 act+$0.01

Coverage

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice